TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT06441890 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05743504 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05743504 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05300503 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04836663 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04836663 — Predictive Biomarker (PRD): PIK3R1 mRNA
Genes: PIK3R1; GRB1
Study NCT06489327 — Predictive Biomarker (PRD): MT2A mRNA
Genes: MT2A; CES1; MT2
Study NCT05626049 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT05484050 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05484050 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02988297 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05619978 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05619978 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04663750 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04663750 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06725719 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT06735690 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05251779 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06735495 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06735495 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06735326 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06104228 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06540872 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05336656 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05543265 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06167603 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT05777720 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05360082 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT05716087 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06101940 — Predictive Biomarker (PRD): DMPK mRNA
Genes: DMPK; DM1PK; MDPK
Study NCT05432466 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study NCT05228730 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06120166 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05679466 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05682079 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT06528964 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06528964 — Predictive Biomarker (PRD): TARDBP mRNA
Genes: TARDBP; TDP43
Study NCT06528964 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06070194 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05781217 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06018363 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT04637698 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06378892 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04017819 — Predictive Biomarker (PRD): SLC38A4 mRNA
Genes: SLC38A4; ATA3; NAT3; SNAT4
Study NCT05762679 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05786716 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05575830 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05409300 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05104216 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06503094 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06130826 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06130826 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05835089 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study NCT04716179 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05172128 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05172128 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05024097 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06015503 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06360809 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05339321 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06240234 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06446882 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05803616 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04939662 — Predictive Biomarker (PRD): SLFN11 mRNA
Genes: SLFN11
Study NCT04939662 — Predictive Biomarker (PRD): POU2F3 mRNA
Genes: POU2F3; OTF11; PLA1
Study NCT04315233 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06353126 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT05681468 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05681468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04943003 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04853355 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04853355 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04791410 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05745454 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05745454 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05727410 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05727410 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05727410 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05727410 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05583201 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05583201 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05451784 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06546566 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06147570 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT04972929 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05555251 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05555251 — Predictive Biomarker (PRD): FCGR2B
Genes: CD32; CD32B; FcgammaRIIb; FcGRIIB
Study NCT05007834 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04908176 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05145335 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06500676 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04727151 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04727151 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06736119 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT05484570 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06117371 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05264025 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05930340 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04703478 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04624880 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT04937036 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05109169 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06322056 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05630768 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06549556 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05043090 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05043090 — Predictive Biomarker (PRD): PRCC mRNA
Genes: PRCC; TPRC
Study NCT05043090 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT06100133 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT06096909 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05727384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05727384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05315700 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05315700 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04590664 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04830137 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04773951 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT06273644 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT01261026 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01261026 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02577094 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06272422 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05834686 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06211673 — Predictive Biomarker (PRD): FOXP1 mRNA
Genes: FOXP1; HSPC215
Study NCT06288945 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05597202 — Predictive Biomarker (PRD): GLP1R mRNA
Genes: GLP1R
Study NCT05845905 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05184998 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05549778 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05801939 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05785585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06491082 — Predictive Biomarker (PRD): NOX4 mRNA
Genes: NOX4; RENOX
Study NCT06491082 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04936841 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT04936841 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04813926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06032026 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06428500 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04494334 — Predictive Biomarker (PRD): CCL18 mRNA
Genes: CCL18; AMAC1; DCCK1; MIP4; PARC; SCYA18
Study NCT00002037 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05667584 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04743453 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05146284 — Predictive Biomarker (PRD): AMN mRNA
Genes: AMN; UNQ513/PRO1028
Study NCT05146284 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT06618859 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06691165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05393713 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06735508 — Predictive Biomarker (PRD): MXD1 mRNA
Genes: MXD1; MAD
Study NCT06735820 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT06734182 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06735599 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06736054 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06194149 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04836832 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT04836832 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05655351 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05655351 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT05880758 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03025360 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT03025360 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT03025360 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT05999396 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT05795049 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05449821 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06503432 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05465161 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT05111561 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT05111561 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT05111561 — Safety Biomarker (SAF): RAS pathway
Study NCT05178550 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT05178550 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05178550 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT06682520 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05264974 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04921241 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04921241 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04921241 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04762888 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04868604 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05104567 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05104567 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05104567 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06732492 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT06528691 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT06528691 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06018337 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06018337 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06018337 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06018337 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05558696 — Predictive Biomarker (PRD): KDM1A mRNA
Genes: KDM1A; AOF2; KDM1; KIAA0601; LSD1
Study NCT05897541 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05309668 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05109364 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT06549530 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06549530 — Surrogate Endpoint (SUR): Neutralizing antibody response
Study NCT05945368 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04962191 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06381076 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04930445 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05290922 — Predictive Biomarker (PRD): CDO1 mRNA
Genes: CDO1
Study NCT05290922 — Predictive Biomarker (PRD): CELF4 mRNA
Genes: CELF4; BRUNOL4
Study NCT06428487 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04979052 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05493761 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT05493761 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT05101096 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05101096 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05101096 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05101096 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05944016 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06578078 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06029283 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06665178 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06665178 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06665178 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06668272 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06456658 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06618352 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06495333 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT05640830 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06356922 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06356922 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT06590779 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05275426 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT06592092 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT05086627 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06593145 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06472583 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06472583 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05248256 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05393791 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06615206 — Predictive Biomarker (PRD): MECP2 mRNA
Genes: MECP2
Study NCT06483048 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT05069129 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01852682 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT05527301 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT06706414 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT06155604 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05204329 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04467983 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05241873 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05031988 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06095505 — Predictive Biomarker (PRD): BBC3 mRNA
Genes: BBC3; PUMA
Study NCT06718452 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06734273 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05103943 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06491433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06567054 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06472518 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT06178419 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05303844 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06490380 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05679570 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06136390 — Predictive Biomarker (PRD): OXTR mRNA
Genes: OXTR
Study NCT05542524 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT06397001 — Predictive Biomarker (PRD): SAA1 mRNA
Genes: SAA1
Study NCT06550011 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06011395 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04912648 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT05605496 — Safety Biomarker (SAF): Netrin-1
Genes: NTN1; NTN1L
Study NCT05477082 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04970134 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT04970134 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT05961358 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06480513 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04759274 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05384119 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT05384119 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL